279 related articles for article (PubMed ID: 37182303)
1. Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria.
Kaiser AM; Forsthuber M; Widhalm R; Granitzer S; Weiss S; Zeisler H; Foessleitner P; Salzer H; Grasl-Kraupp B; Moshammer H; Hartmann C; Uhl M; Gundacker C
Ecotoxicol Environ Saf; 2023 Jul; 259():115006. PubMed ID: 37182303
[TBL] [Abstract][Full Text] [Related]
2. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
[TBL] [Abstract][Full Text] [Related]
3. Prenatal per- and polyfluoroalkyl substances (PFAS) exposure in relation to preterm birth subtypes and size-for-gestational age in the LIFECODES cohort 2006-2008.
Siwakoti RC; Cathey A; Ferguson KK; Hao W; Cantonwine DE; Mukherjee B; McElrath TF; Meeker JD
Environ Res; 2023 Nov; 237(Pt 2):116967. PubMed ID: 37634691
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
[TBL] [Abstract][Full Text] [Related]
5. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
[TBL] [Abstract][Full Text] [Related]
6. Prenatal exposures to per- and polyfluoroalkyl substances and epigenetic aging in umbilical cord blood: The Healthy Start study.
Niemiec SS; Kechris K; Pattee J; Yang IV; Adgate JL; Calafat AM; Dabelea D; Starling AP
Environ Res; 2023 Aug; 231(Pt 2):116215. PubMed ID: 37224946
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.
Hall SM; Zhang S; Hoffman K; Miranda ML; Stapleton HM
Chemosphere; 2022 May; 295():133873. PubMed ID: 35143854
[TBL] [Abstract][Full Text] [Related]
10. Associations of prenatal exposure to perfluoroalkyl substances with preterm birth: A family-based birth cohort study.
Yu Y; Qin XD; Bloom MS; Chu C; Dai X; Li QQ; Chen ZX; Kong ML; Xie YQ; Meng WJ; Yang BY; Hu LW; Zeng XW; Zhao XM; Zhou Y; Dong GH
Environ Res; 2022 Nov; 214(Pt 1):113803. PubMed ID: 35810818
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
[TBL] [Abstract][Full Text] [Related]
12. Per- and polyfluoroalkyl substances (PFAS) and fetal growth: A nation-wide register-based study on PFAS in drinking water.
Säve-Söderbergh M; Gyllenhammar I; Schillemans T; Lindfeldt E; Vogs C; Donat-Vargas C; Halldin Ankarberg E; Glynn A; Ahrens L; Helte E; Åkesson A
Environ Int; 2024 May; 187():108727. PubMed ID: 38735074
[TBL] [Abstract][Full Text] [Related]
13. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
[TBL] [Abstract][Full Text] [Related]
14. Impact of Gestational Exposure to Individual and Combined Per- and Polyfluoroalkyl Substances on a Placental Structure and Efficiency: Findings from the Ma'anshan Birth Cohort.
Gan H; Xing Y; Tong J; Lu M; Yan S; Huang K; Wu X; Tao S; Gao H; Pan Y; Dai J; Tao F
Environ Sci Technol; 2024 Apr; 58(14):6117-6127. PubMed ID: 38525964
[TBL] [Abstract][Full Text] [Related]
15. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
[TBL] [Abstract][Full Text] [Related]
16. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
[TBL] [Abstract][Full Text] [Related]
17. Associations of Maternal Stress, Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFAS), and Demographic Risk Factors with Birth Outcomes and Offspring Neurodevelopment: An Overview of the ECHO.CA.IL Prospective Birth Cohorts.
Eick SM; Enright EA; Geiger SD; Dzwilewski KLC; DeMicco E; Smith S; Park JS; Aguiar A; Woodruff TJ; Morello-Frosch R; Schantz SL
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467168
[TBL] [Abstract][Full Text] [Related]
18. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
19. Extractable Organofluorine Analysis in Pooled Human Serum and Placental Tissue Samples from an Austrian Subpopulation-A Mass Balance Analysis Approach.
Kaiser AM; Forsthuber M; Aro R; Kärrman A; Gundacker C; Zeisler H; Foessleitner P; Salzer H; Hartmann C; Uhl M; Yeung LWY
Environ Sci Technol; 2021 Jul; 55(13):9033-9042. PubMed ID: 34133125
[TBL] [Abstract][Full Text] [Related]
20. Per- and polyfluoroalkyl substances exposure during pregnancy and adverse pregnancy and birth outcomes: A systematic review and meta-analysis.
Gao X; Ni W; Zhu S; Wu Y; Cui Y; Ma J; Liu Y; Qiao J; Ye Y; Yang P; Liu C; Zeng F
Environ Res; 2021 Oct; 201():111632. PubMed ID: 34237336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
